Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells

Miao, Yuxuan, Yang, Hanseul, Levorse, John, Yuan, Shaopeng, Polak, Lisa, Sribour, Megan, Singh, Bhuvanesh, Rosenblum, Michael D. +1 more·2019·Cell

Cited by (303)

Items 101–200 of 303

  1. Implications of Tumor–Immune Coevolution on Cancer Evasion and Optimized Immunotherapy
    Jason Thomas George, Herbert Levine · 2021 · Trends in cancer
  2. Biomineralization-Tuned Nanounits Reprogram the Signal Transducer and Activator of Transcription 3 Signaling for Ferroptosis-Immunotherapy in Cancer Stem Cells
    Youbo Zhao, Yang Fei, Yang Zhao, Menghuan Li, Yan Hu, Kaiyong Cai, Shu‐Hong Yu, Zhong Yuan Luo · 2024 · ACS Nano
  3. MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer
    Masayuki Hagiwara, Atsushi Fushimi, Atrayee Bhattacharya, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Oya, Henry G. Withers, Qiang Hu, Tao Liu, Song Liu et al. · 2022 · OncoImmunology
  4. CD80 on skin stem cells promotes local expansion of regulatory T cells upon injury to orchestrate repair within an inflammatory environment
    Jingyun Luan, Cynthia Truong, Aleksandra Vuchkovska, Weijie Guo, Jennifer L. Good, Bijun Liu, Audrey Gang, Nicole R. Infarinato, Katherine S. Stewart, Lisa Polak et al. · 2024 · Immunity
  5. Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development
    Hsiang‐Wei Huang, Cheng‐Chih Chang, Chia‐Siu Wang, Kwang‐Huei Lin · 2021 · Cells
  6. Tumor-Infiltrating CD20+ B Lymphocytes: Significance and Prognostic Implications in Oral Cancer Microenvironment
    Faustino Julián Suárez-Sánchez, Paloma Lequerica–Fernández, Juan Pablo Rodrigo, Francisco Hermida‐Prado, Julián Suárez-Canto, Tania Rodríguez‐Santamarta, Francisco Domínguez-Iglesias, Juana Maria Garcia-Pedrero, Juan Carlos de Vicente · 2021 · Cancers
  7. Cancer-Associated Fibroblasts Facilitate Squamous Cell Carcinoma Lung Metastasis in Mice by Providing TGFβ-Mediated Cancer Stem Cell Niche
    Xueke Shi, Jingjing Luo, Kelsey J. Weigel, Spencer C. Hall, Danfeng Du, Fanglong Wu, Michael C. Rudolph, Hongmei Zhou, Christian D. Young, Xiao‐Jing Wang · 2021 · Frontiers in Cell and Developmental Biology
  8. Cancer stem cells: Signaling pathways and therapeutic targeting
    Joyeeta Talukdar, Tryambak Pratap Srivastava, Om Saswat Sahoo, Abhibroto Karmakar, Avdhesh K. Rai, Anupam Sarma, Gayatri Gogoi, Mohammed Saeed Alqahtani, Mohamed Abd Elhamid Abbas, Ruby Dhar et al. · 2023 · MedComm – Oncology
  9. The emerging role of cancer cell plasticity and cell-cycle quiescence in immune escape
    Sara Bruschini, Gennaro Ciliberto, Rita Mancini · 2020 · Cell Death and Disease
  10. Cancer stem cells release interleukin-33 within large oncosomes to promote immunosuppressive differentiation of macrophage precursors
    Hannah L Erickson, Sachiko Taniguchi, Anish Raman, Justin J. Leitenberger, Sanjay V. Malhotra, Naoki Oshimori · 2024 · Immunity
  11. Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway
    Ryan J. Green, Mark Howell, Roukiah Khalil, Rajesh R. Nair, Jiyu Yan, Elspeth A. Foran, Sandhyabanu Katiri, Jit Banerjee, Mandip S. Singh, Srinivas Nagaraj Bharadwaj et al. · 2019 · Scientific Reports
  12. Single-cell transcriptomic analysis reveals the critical molecular pattern of UV-induced cutaneous squamous cell carcinoma
    Guorong Yan, Liang Li, Sibo Zhu, Yuhao Wu, Yeqiang Liu, Lude Zhu, Zijun Zhao, Fei Wu, Ning Jia, Caihe Liao et al. · 2021 · Cell Death and Disease
  13. HIF in Gastric Cancer: Regulation and Therapeutic Target
    Mengqing Li, Li Guan, Xiaodong Yang, Weihua Yin, Guoqing Lv, Shubin Wang · 2022 · Molecules
  14. A Self‐Assembly Nano‐Prodrug for Combination Therapy in Triple‐Negative Breast Cancer Stem Cells
    Chongzhi Wu, Fu Zhang, Bowen Li, Zhiyao Li, Xin Xie, Yong Xiang Huang, Zhuo Yao, Yuan Chen, Ping Yuan, Weidong Pan · 2023 · Small
  15. The Tumor Microenvironment in SCC: Mechanisms and Therapeutic Opportunities
    Nádia Ghinelli Amôr, Paulo Sérgio da Silva Santos, Ana Paula Campanelli · 2021 · Frontiers in Cell and Developmental Biology
  16. Epigenetic regulation of autophagy: A key modification in cancer cells and cancer stem cells
    Harpreet Kaur Mandhair, Urban Novak, Ramin Radpour · 2021 · World Journal of Stem Cells
  17. LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor β Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models
    Weidong Xu, Yuefeng Yang, Zebin Hu, Maria Head, Kathy A. Mangold, Megan E. Sullivan, Edward Wang, Poornima Saha, Kamalakar Gulukota, Donald L. Helseth et al. · 2020 · Human Gene Therapy
  18. rtcisE2F promotes the self-renewal and metastasis of liver tumor-initiating cells via N6-methyladenosine-dependent E2F3/E2F6 mRNA stability
    Zhenzhen Chen, Lan Huang, Kaili Wang, Lulu Zhang, Xiang Zhong, Zhongyi Yan, Benyu Liu, Pingping Zhu · 2022 · Science China Life Sciences
  19. The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models <i>In Vivo</i> Reflects a Complex Balance between Tumor-Suppressive and Proprogression Activities of TGFβ
    Yang, Yuan, Yang, Howard H., Tang, Binwu, Wu, Alex Man Lai, Flanders, Kathleen C., Moshkovich, Nellie, Weinberg, Douglas S., Welsh, Michael A., Weng, Jia, Ochoa, Humberto J. et al. · 2020 · Clinical Cancer Research
  20. Ferroptosis and Cancer Immunotherapy
    Jumei Yin, Xingqi Meng, Lixuan Peng, Wei Xie, Xuan Liu, Weiguo He, Suyun Li · 2022 · Current Molecular Medicine
  21. Further knowledge and developments in resistance mechanisms to immune checkpoint inhibitors
    Léa Berland, Zeina Gabr, Michelle Chang, Marius Ilié, Véronique Hofman, Guylène Rignol, François Ghiringhelli, Baharia Mograbi, Mohamad Rashidian, Paul M Hofman · 2024 · Frontiers in Immunology
  22. Cancer immunotherapy: A comprehensive appraisal of its modes of application (Review)
    Mira Hoteit, Zeina Oneissi, Ranim Reda, Fadi Wakim, Amar Zaidan, Mohammad Farran, Elie Abi Khalil, Mirvat El‐Sibai · 2021 · Oncology Letters
  23. TGFβ: Signaling Blockade for Cancer Immunotherapy
    Szu‐Ying Chen, Ons Mamaï, Rosemary J. Akhurst · 2021 · Annual Review of Cancer Biology
  24. Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
    Xiao-Hai Song, Lan Yang, Xiuli Zheng, Qianyu Zhu, Xu-Liang Liao, Kai Liu, Weihan Zhang, Qunyong Peng, Yunfeng Zhu, Lin-Yong Zhao et al. · 2023 · MedComm
  25. Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells
    Yuta Kimura, Ryouichi Tsunedomi, Kiyoshi Yoshimura, Satoshi Matsukuma, Yoshitaro Shindo, Hiroto Matsui, Yukio Tokumitsu, Shin Yoshida, Michihisa Iida, Nobuaki Suzuki et al. · 2022 · Annals of Surgical Oncology
  26. IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells
    Kai Zhang, Wenhao Hu, Feng Li, Chunli Wen, Lingxiao Zhou, Lei Zhang, Jingyao Lian, Shasha Liu, Shumin Wang, Yi Zhang · 2024 · British Journal of Cancer
  27. The Role of PRMT5 in Immuno-Oncology
    Yoshinori Abe, Takumi Sano, Nobuyuki Tanaka · 2023 · Genes
  28. Identification of cis-HOX-HOXC10 axis as a therapeutic target for colorectal tumor-initiating cells without APC mutations
    Zhenzhen Chen, Jiayi Wu, Benyu Liu, Guangtan Zhang, Zhiwei Wang, Lulu Zhang, Kaili Wang, Zusen Fan, Pingping Zhu · 2021 · Cell Reports
  29. Characterization of gastric cancer stem-like molecular features, immune and pharmacogenomic landscapes
    Chen Wei, Mingkai Chen, Wenying Deng, Liangyu Bie, Yijie Ma, Chi Zhang, Kangdong Liu, Wei Shen, Shuyi Wang, Chaogang Yang et al. · 2021 · Briefings in Bioinformatics
  30. Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells
    Linheng Li, Roy A. Jensen · 2023 · Cancer Research
  31. Modulation of Immune Components on Stem Cell and Dormancy in Cancer
    Xiaofan Jiang, Lu Liang, Guanglei Chen, Caigang Liu · 2021 · Cells
  32. Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis
    Deepti Singh, Mohammad Afsar Khan, Hifzur Rahman Siddique · 2022 · Biochemical Pharmacology
  33. Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma
    Laura Lorenzo-Sanz, Marta Lopez-Cerda, Victoria da Silva-Diz, Marta H. Artés, Sandra Llop, Rosa Maria Penin, Josep Oriol Bermejo, Eva González‐Suárez, Manel Esteller, Francesc Viñals et al. · 2024 · Nature Communications
  34. Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities
    Sivapar V. Mathan, Rana Pratap Singh · 2025 · Cancers
  35. TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak
    Catalina Rozalén, Irene Sangrador, Silvia Avalle, Sandra Blasco-Benito, Panagiota Tzortzi, María Sanz‐Flores, José Ángel Palomeque, Pau Torren-Duran, Mariona Dalmau, Héléna Brunel et al. · 2025 · Cancer Cell
  36. TGF-β signaling regulates SPOP expression and promotes prostate cancer cell stemness
    Chenchen Jiao, Tong Meng, Chenyu Zhou, Xinbo Wang, Ping Wang, Meiling Lü, Xiao Tan, Qing Wei, Xin Ge, Jiali Jin · 2020 · Aging
  37. Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells
    Haojun Shi, Yisi Yang · 2021 · Cancer Medicine
  38. Mechanisms of immune evasion by head and neck cancer stem cells
    Flávia Caló de Aquino Xavier, Jamerson Carvalho Silva, Camila Oliveira Rodini, Maria Fernanda Setúbal Destro Rodrigues · 2022 · Frontiers in Oral Health
  39. Alternative immune checkpoints in immunoregulatory profile of cancer stem cells
    Keywan Mortezaee, Jamal Majidpoor · 2023 · Heliyon
  40. Multidimensional analysis of tumor stem cells: from biological properties, metabolic adaptations to immune escape mechanisms
    Han Han, Ting He, Yingfan Wu, Tianmei He, Weiqiang Zhou · 2024 · Frontiers in Cell and Developmental Biology
  41. Fibroblasts in cancer: Defining target structures for therapeutic intervention
    Maximilian Boesch, Florent Baty, Holger F. Rumpold, Sieghart Sopper, Dominik Georg Friedrich Wolf, Martin Hugo Brutsche · 2019 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  42. A Novel HCC Prognosis Predictor EEF1E1 Is Related to Immune Infiltration and May Be Involved in EEF1E1/ATM/p53 Signaling
    Ruiqin Han, Penghui Feng, Junyi Pang, Dingfeng Zou, Xiaolu Li, Chao Geng, Lili Li, Jie Min, Jing Shi · 2021 · Frontiers in Oncology
  43. The relevance between hypoxia-dependent spatial transcriptomics and the prognosis and efficacy of immunotherapy in claudin-low breast cancer
    Huizhi Sun, Yanlei Li, Yanhui Zhang, Xiulan Zhao, Xueyi Dong, Yuhong Guo, Jing Mo, Na Che, Xinchao Ban, Fan Li et al. · 2023 · Frontiers in Immunology
  44. Epigenetic control of immunoevasion in cancer stem cells
    Claudia Galassi, Manel Esteller, Ilio Vitale, Lorenzo Galluzzi · 2024 · Trends in cancer
  45. Acquired Resistance to Immune Checkpoint Blockade Therapies
    Xianda Zhao, Dechen Wangmo, Matthew J. Robertson, Subbaya Subramanian · 2020 · Cancers
  46. Cancer stem cells: Bridging microenvironmental interactions and clinical therapy
    Huiling Wang, Junshu Li, Fei Du, Hongxin Deng · 2025 · Clinical and Translational Medicine
  47. Bacteria-mediated cancer therapy (BMCT): Therapeutic applications, clinical insights, and the microbiome as an emerging hallmark of cancer
    Mrunali Jayaprakash, Deekshit Vijaya Kumar, Gunimala Chakraborty, Anirban Chakraborty, Vinod Kumar · 2025 · Biomedicine & Pharmacotherapy
  48. Cancer resistance to immunotherapy: What is the role of cancer stem cells?
    Gourab Gupta, George Merhej, Shakthika Saravanan, Hexin Chen · 2022 · Cancer Drug Resistance
  49. The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity
    Daria S. Chulpanova, Albert Anatolyevich Rizvanov, Valeriya V. Solovyeva · 2022 · International Journal of Molecular Sciences
  50. Immune privilege of skin stem cells: What do we know and what can we learn?
    Judith Agudo · 2020 · Experimental Dermatology
  51. CXCR4+ mammary gland macrophageal niche promotes tumor initiating cell activity and immune suppression during tumorigenesis
    Eun-Mi Lee, Jason J Hong, Gabriel Samcam Vargas, Natalie Sauerwald, Yong Wei, Xiang Hang, Chandra L. Theesfeld, Jean Arly Volmar, Jennifer M. Miller, Wei Wang et al. · 2025 · Nature Communications
  52. Progress in research into the role of abnormal glycosylation modification in tumor immunity
    Huimin Liu, Lele Ma, Bo Cao, Junzhi Lin, Li Han, Chunyu Li, Runchun Xu, Dingkun Zhang · 2020 · Immunology Letters
  53. Research progress of CD80 in the development of immunotherapy drugs
    Lanying Li, Lei Yang, Depeng Jiang · 2024 · Frontiers in Immunology
  54. Immunoregulatory Potential of Exosomes Derived from Cancer Stem Cells
    Shannon M. Clayton, Joehleen A. Archard, Joseph Wagner, D. G. Farwell, A. Bewley, Angela M. Beliveau, A. Birkeland, Shyam S. Rao, Marianne Abouyared, Peter C. Belafsky et al. · 2019 · Stem Cells and Development
  55. Supervised learning of high-confidence phenotypic subpopulations from single-cell data
    Tao Ren, Canping Chen, Alexey Valeryevich Danilov, Susan Liu, Xiangnan Guan, Shunyi Du, Xiwei Wu, Mara H. Sherman, Paul T. Spellman, Lisa M. Coussens et al. · 2023 · Nature Machine Intelligence
  56. Tumor Microenvironment Metabolism‐Modulating Nanomedicines for Enhancing Anti‐Tumor Immunity
    Jiajie Chen, S. Fei, Zhihao Cao, Xinchun Liu, Weizhi Ji, Hangrong Chen, Yuyu Niu, Zebin Yang · 2025 · Small
  57. Matrix stiffness drives squamous cell carcinoma progression via a Piezo1-mediated mechanotransduction feedback loop
    Zixi Jiang, Yantao Xu, Ying Wang, Zhuxin Dong, Wenjihao Hu, Juan Su, Lisha Wu, Yi He, Lin Zhu, Dan Jian et al. · 2025 · Journal of Advanced Research
  58. Extracellular vesicles in non-small cell lung cancer stemness and clinical applications
    Prita Pandya, Dania S. Al-Qasrawi, Skyeler M. Klinge, Verline Justilien · 2024 · Frontiers in Immunology
  59. The tumor-promoting effects of the adaptive immune system: a cause of hyperprogressive disease in cancer?
    Fabrizio Marcucci, Cristiano Rumio · 2020 · Cellular and Molecular Life Sciences
  60. Unravelling the landscape of skin cancer through single-cell transcriptomics
    Ankit Srivastava, Tomas Bencomo, Ishani Das, Carolyn S. Lee · 2022 · Translational Oncology
  61. Suppression of Cancer Cell Stemness and Drug Resistance via MYC Destabilization by Deubiquitinase USP45 Inhibition with a Natural Small Molecule
    Xiao Tu, Chuncheng Li, Wen Yang Sun, Xi Tian, Qiufu Li, Shaoxin Wang, Xiaoling Ding, Zhen Huang · 2023 · Cancers
  62. RAB27B Drives a Cancer Stem Cell Phenotype in NSCLC Cells Through Enhanced Extracellular Vesicle Secretion
    Kayleah M. Meneses, Prita Pandya, Jennifer A. Lindemann, Dania S. Al-Qasrawi, Ryan A. Argo, Celeste M. Weems, Danielle J. Beetler, Geraldine Vidhya Vijay, Irene K. Yan, Joy Wolfram et al. · 2023 · Cancer Research Communications
  63. Tumor-immune metaphenotypes orchestrate an evolutionary bottleneck that promotes metabolic transformation
    Jeffrey West, Frederika Rentzeperis, Casey Erin Adam, Rafael Bravo, Kimberly A. Luddy, Mark Robertson‐Tessi, Alexander R.A. Anderson · 2024 · Frontiers in Immunology
  64. How stem cells respond to infection, inflammation and ageing
    Enzo Z. Poirier · 2025 · Nature reviews. Immunology
  65. The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy
    Ola Hussein, Menatallah Rayan, Tasnim R. Matarid, Dana H. Elkhalifa, Hanan H. Abunada, Lubna Therachiyil, Ashraf A. Khalil, Shahab Uddin M.S., Cristina Maccalli, Hesham Mohamed Korashy · 2025 · Journal of Experimental & Clinical Cancer Research
  66. Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer
    Haojun Shi, Yiusing Tsang, Yisi Yang · 2022 · BMC Cancer
  67. Stress in the metastatic journey – the role of cell communication and clustering in breast cancer progression and treatment resistance
    Eloïse M Grasset, S. Barillé-Nion, Philippe P. Juin · 2024 · Disease Models & Mechanisms
  68. Histone Demethylase KDM4C Is Required for Ovarian Cancer Stem Cell Maintenance
    Guoqing Chen, Ping Ye, Rongsong Ling, Fa Zeng, Xiong-Shan Zhu, Lu Chen, Yan Huang, Ling Xu, Xiaoying Xie · 2020 · Stem Cells International
  69. Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer
    Madhuvanthi Giridharan, Vasu Rupani, Satarupa Banerjee · 2022 · ACS Pharmacology & Translational Science
  70. The epigenome and the many facets of cancer drug tolerance
    Paul C. Moore, Kurt W. Henderson, Marie Classon · 2023 · Advances in cancer research
  71. Tumor-initiating stem cells fine-tune the plasticity of neutrophils to sculpt a protective niche
    Weijie Guo, Jingyun Luan, Xuejie Huang, Daniel Leon, Sophie Gang, Benjamin Nicholson, Breanna Bertacchi, Diana Bolotin, Mark William Lingen, Alexander T. Pearson et al. · 2025 · Cancer Cell
  72. Synthetic lethality in cancer therapy: Mechanisms, models and clinical translation for overcoming therapeutic resistance
    Junyan Li, Liyuan Zhang, Yan Shang, Juan Liu, Hailong Zhao · 2026 · Clinical and Translational Medicine
  73. Identification of cell subpopulations associated with disease phenotypes from scRNA-seq data using PACSI
    Chonghui Liu, Yan Zhang, Xin Gao, Guohua Wang · 2023 · BMC Biology
  74. The mast cell-T lymphocyte axis impacts cancer: Friend or foe?
    Vinicius Kannen, Denis M. Grant, Jason B. Matthews · 2024 · Cancer Letters
  75. Single-cell RNA sequencing analysis reveals the distinct features of colorectal cancer with or without Fusobacterium nucleatum infection in PD-L1 blockade therapy
    Tingting Ding, Qian Chen, Hu Liu, Heping Zhang, Yuefang Sun, Lamei Zhao, Yaohui Gao, Qing Wei · 2024 · Heliyon
  76. CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma
    Jiaojiao Xu, Zhe Li, Qinli Tong, Sihang Zhang, Jianchen Fang, Aihua Wu, Guoguang Wei, Chen Zhang, Sheng Yu, Binbin Zheng et al. · 2025 · Nature Communications
  77. Identification of an m6A Regulators-Mediated Prognosis Signature For Survival Prediction and Its Relevance to Immune Infiltration in Melanoma
    Liuxing Wu, Xin Hu, Hong Dai, Kexin Chen, Ben Liu · 2021 · Frontiers in Cell and Developmental Biology
  78. Masters of adaptation: How cancer and immune cell plasticity mediates tumor progression
    Sheera R. Rosenbaum, Kaiah M. Fields, Heide L. Ford · 2025 · PLoS Biology
  79. Identification of Pyroptosis-Relevant Signature in Tumor Immune Microenvironment and Prognosis in Skin Cutaneous Melanoma Using Network Analysis
    Yun Zhu, Dan Han, Hongjue Duan, Qi Rao, Yike Qian, Qiaoyun Chen, Xiao Du, Huanyu Ni, Siliang Wang · 2023 · Stem Cells International
  80. Bmi1 Severs as a Potential Tumor-Initiating Cell Marker and Therapeutic Target in Esophageal Squamous Cell Carcinoma
    Xiaochen Wang, Kang Li, Maosheng Cheng, Ganping Wang, Hui Han, Fangfang Chen, Wenjing Liao, Zhi Chen, Jianwen Chen, Yong Bao et al. · 2020 · Stem Cells International
  81. Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives
    Ari Hashimoto, Shigeru Hashimoto · 2024 · Cancers
  82. Co-targeting BMI1 and MYC to eliminate cancer stem cells in squamous cell carcinoma
    Zhen Qin, Shuo Liu, Yunfei Zheng, Yujia Wang, Yiwen Chen, Xin Peng, Lingfei Jia · 2025 · Cell Reports Medicine
  83. Double-sided niche regulation in skin stem cell and cancer: mechanisms and clinical applications
    Quoc Thao Trang Pham, Yung‐Che Kuo, Wei‐Ling Chang, Hao-Jui Weng, Yen-Hua Huang · 2025 · Molecular Cancer
  84. Molecular subtypes of osteosarcoma classified by cancer stem cell related genes define immunological cell infiltration and patient survival
    Lei Guo, Taiqiang Yan, Wei Guo, Jianfang Niu, Wei Wang, Tingting Ren, Yi Huang, Jiuhui Xu, Boyang Wang · 2022 · Frontiers in Immunology
  85. Nestin-GFP transgene labels immunoprivileged bone marrow mesenchymal stem cells in the model of ectopic foci formation
    Dmitriy Vladimirovich Karpenko, Капранов Николай Михайлович, Alexey Bigildeev · 2022 · Frontiers in Cell and Developmental Biology
  86. Identification and validation of KIF23 as a hypoxia-regulated lactate metabolism-related oncogene in uterine corpus endometrial carcinoma
    Tao Wang, Xiaotong Peng, Wenwen Liu, Mei Ji, Jing Ping Sun · 2024 · Life Sciences
  87. Chronic High-Salt Diet Activates Tumor-Initiating Stem Cells Leading to Breast Cancer Proliferation
    Lisa Tucker, Umer Ali, Roy Zent, Deborah Ann Lannigan, Jeffrey C. Rathmell, Venkataswarup Tiriveedhi · 2024 · Cells
  88. PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-6
    Longzhu Zhong, Wanlin Tan, Qianqiong Yang, Zhaowei Zou, Rui Zhou, Yongsheng Huang, Zhenghua Qiu, Kehong Zheng, Zong-hai Huang · 2022 · Journal of Gastrointestinal Oncology
  89. Neural induction drives body axis formation during embryogenesis, but a neural induction-like process drives tumorigenesis in postnatal animals
    Ying Cao · 2023 · Frontiers in Cell and Developmental Biology
  90. Development and validation of a novel DNA damage repair-related long non-coding RNA signature in predicting prognosis, immunity, and drug sensitivity in uterine corpus endometrial carcinoma
    Tao Wang, Mei Ji, Wenwen Liu, Jing Ping Sun · 2023 · Computational and Structural Biotechnology Journal
  91. Identification of ONECUT3 as a stemness-related transcription factor regulating NK cell-mediated immune evasion in pancreatic cancer
    Haojun Shi, Yiusing Tsang, Yisi Yang, Hok Leong Chin · 2023 · Scientific Reports
  92. T Cells Expressing Receptor Recombination/Revision Machinery Are Detected in the Tumor Microenvironment and Expanded in Genomically Over-unstable Models
    Gaia Morello, Valeria Cancila, Massimo La Rosa, Giovanni Germano, Daniele Lecis, Vito Amodio, Federica Zanardi, Fabio Iannelli, Daniele Greco, Laura La Paglia et al. · 2021 · Cancer Immunology Research
  93. CD93 in macrophages: A novel target for atherosclerotic plaque imaging?
    Chen Hsien Su, Yeming Han, Bin Qu, Chao Zhang, Ting Bo Liang, Feng Gao, Guihua Hou · 2022 · Journal of Cellular and Molecular Medicine
  94. Recent developments in unraveling signaling mechanisms underlying drug resistance due to cancer stem-like cells
    Abdul Quaiyoom Khan, Khalid Rashid, Abdulhadi A. AlAmodi, Syed Shadab Raza, Shahab Uddin M.S. · 2020 · Current Opinion in Pharmacology
  95. Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma
    Wei Feng, Ziyi He, Liang Shi, Zheng Zhu, Haitao Ma · 2023 · Biochemical Genetics
  96. PIPET: predicting relevant subpopulations in single-cell data using phenotypic information from bulk data
    Xinjia Ruan, Yu Cheng, Yuqing Ye, Yuhang Wang, Xinyi Chen, Yuqing Yang, Tiantian Liu, Fangrong Yan · 2024 · Briefings in Bioinformatics
  97. Adult tissue-specific stem cell interaction: novel technologies and research advances
    Xutao Luo, Ziyi Liu, Ruoshi Xu · 2023 · Frontiers in Cell and Developmental Biology
  98. The implication of integrative multiple RNA modification-based subtypes in gastric cancer immunotherapy and prognosis
    Xiangnan Zhang, Liuxing Wu, Liqing Jia, Xin Hu, Yanxin Yao, Huahuan Liu, Junfu Ma, Wei J. Wang, Lian Li, Kexin Chen et al. · 2024 · iScience
  99. Applications of Single-Cell Sequencing in Dermatology
    Dandan Zou, Jue Qi, Wenjuan Wu, Dan Xu, Ying Tu, Tongyun Liu, Juan Zhang, Xing Li, Fengyan Lu, Li He · 2021 · Medical Science Monitor
  100. Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
    Patrik Andersson, C. Ostheimer · 2019 · Frontiers in Immunology